H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice
The risk of secondary infection with SARS-CoV-2 and influenza A virus is becoming a practical problem that must be addressed as the flu season merges with the COVID-19 pandemic. As SARS-CoV-2 and influenza A virus have been found in patients, understanding the in vivo characteristics of the secondar...
Main Authors: | Heng Li, Xin Zhao, Yurong Zhao, Jing Li, Huiwen Zheng, Mengyi Xue, Lei Guo, Jian Zhou, Jinling Yang, Yuanyuan Zuo, Yanli Chen, Zening Yang, Qiqi Fan, Li Qin, Haijing Shi, Longding Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2021.1938241 |
Similar Items
-
Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor
by: Ahmed A. Al-Karmalawy, et al.
Published: (2021-05-01) -
The Abundant Distribution and Duplication of SARS-CoV-2 in the Cerebrum and Lungs Promote a High Mortality Rate in Transgenic hACE2-C57 Mice
by: Heng Li, et al.
Published: (2024-01-01) -
A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration
by: Xilin Wu, et al.
Published: (2021-10-01) -
Computational design of medicinal compounds to inhibit RBD-hACE2 interaction in the Omicron variant: unveiling a vulnerable target site
by: Muhammad Shahab, et al.
Published: (2023-01-01) -
The pH Effects on SARS-CoV and SARS-CoV-2 Spike Proteins in the Process of Binding to hACE2
by: Yixin Xie, et al.
Published: (2022-02-01)